Drugs for Gastrointestinal Diseases Practice Questions

Q: Which selective 5-HT4 agonist is useful in gastroesophageal reflux disease and lacks arrhythmogenic properties?

Tegaserod. **Explanation** **Correct Answer: D. Tegaserod** **Mechanism and Rationale:** Tegaserod is a **selective 5-HT4 receptor partial agonist**. Activation of 5-HT4 receptors on the presynaptic terminals of enteric neurons triggers the release of acetylcholine, which enhances the propulsive movement of the GI tract (prokinetic effect) and increases lower esophageal sphincter (LES) tone. Unlike older prokinetics, Tegaserod is highly selective for the 5-HT4 receptor and **does not block hERG potassium channels**. This lack of hERG inhibition means it does not cause QT interval prolongation or life-threatening ventricular arrhythmias (Torsades de Pointes), making it safer from a cardiac standpoint than drugs like Cisapride. **Analysis of Incorrect Options:** * **A. Buspirone:** An anxiolytic that acts as a **5-HT1A partial agonist**. It has no significant prokinetic activity. * **B. Sumatriptan:** A **5-HT1B/1D agonist** used primarily in the acute treatment of migraine; it causes vasoconstriction rather than GI motility. * **C. Cisapride:** While it is a 5-HT4 agonist used for GERD, it is notorious for causing **cardiac arrhythmias** (Torsades de Pointes) due to its off-target blockade of K+ channels. It has been withdrawn or strictly restricted in many markets. **NEET-PG High-Yield Pearls:** * **Prucalopride:** A newer, highly selective 5-HT4 agonist currently preferred for chronic constipation with an excellent cardiac safety profile. * **Cisapride/Mosapride/Itopride:** Often compared in exams. Mosapride and Itopride are considered safer alternatives to Cisapride as they lack significant QT-prolonging effects. * **Tegaserod Status:** Though safer than Cisapride regarding arrhythmias, it was briefly withdrawn due to an association with ischemic cardiovascular events (MI/Stroke) but has been reintroduced for restricted use in specific IBS-C cases.

Q: Stimulant purgatives are contraindicated in which of the following conditions?

Subacute intestinal obstruction. **Explanation:** **1. Why Subacute Intestinal Obstruction is the Correct Answer:** Stimulant purgatives (e.g., Bisacodyl, Senna, Castor oil) work by irritating the intestinal mucosa or stimulating the myenteric plexus, leading to increased propulsive peristaltic activity. In the presence of a mechanical obstruction (like subacute intestinal obstruction), forcing peristalsis against a blocked lumen can lead to severe abdominal cramps, vomiting, and—most critically—**intestinal perforation or ischemia**. Therefore, any form of bowel obstruction is an absolute contraindication for stimulant laxatives. **2. Analysis of Incorrect Options:** * **A. Bedridden patients:** These patients often suffer from constipation due to lack of mobility. While bulk-forming laxatives or stool softeners are preferred first-line, stimulant purgatives are **not contraindicated** and are frequently used for short-term relief. * **B. Before abdominal radiography:** Stimulant purgatives (like Bisacodyl) are actually **indicated** before abdominal X-rays or colonoscopies to clear the bowel of fecal matter, ensuring better visualization of the anatomy. * **D. All of these:** Incorrect, as the contraindication is specific to obstructive pathologies. **3. NEET-PG High-Yield Pearls:** * **Classification:** Stimulant purgatives are also known as "Irritant purgatives." * **Castor Oil:** Contains ricinoleic acid; it is unique because it acts primarily in the small intestine. It is now largely obsolete for constipation. * **Anthraquinones (Senna/Cascara):** Can cause **Melanosis Coli** (brownish-black pigmentation of the colonic mucosa) upon chronic use. * **Contraindications:** Apart from obstruction, they are contraindicated in undiagnosed abdominal pain, acute appendicitis, and late pregnancy (may induce pelvic congestion/reflex uterine contractions).

Q: Which drug is not effective against Helicobacter pylori?

Erythromycin. ### Explanation The correct answer is **Erythromycin**. **1. Why Erythromycin is the correct answer:** While *Helicobacter pylori* is a Gram-negative bacterium, it is inherently resistant to **Erythromycin** in vivo. Although Erythromycin shows some activity in vitro, it is unstable in the acidic environment of the stomach. In contrast, **Clarithromycin** (a newer macrolide) is a cornerstone of *H. pylori* therapy because it is more acid-stable, achieves higher mucosal concentrations, and has superior efficacy against the organism. **2. Why the other options are incorrect:** * **Colloidal Bismuth (A):** Bismuth subsalicylate or colloidal bismuth subcitrate has direct bactericidal effects on *H. pylori*, prevents bacterial adhesion to the gastric mucosa, and inhibits bacterial enzymes (urease). It is a key component of "Bismuth Quadruple Therapy." * **Metronidazole (B):** This nitroimidazole is effective against anaerobic bacteria and microaerophilic organisms like *H. pylori*. It is frequently used in patients allergic to penicillin or in quadruple therapy regimens. * **Amoxicillin (C):** This is a primary bactericidal agent used in "Standard Triple Therapy." Resistance to amoxicillin remains remarkably low, making it a reliable first-line choice. **3. NEET-PG High-Yield Pearls:** * **Standard Triple Therapy (7–14 days):** PPI + Amoxicillin + Clarithromycin (Mnemonic: **PAC**). * **Bismuth Quadruple Therapy:** PPI + Bismuth + Metronidazole + Tetracycline (Used if Clarithromycin resistance is >15%). * **Sequential Therapy:** 5 days of PPI + Amoxicillin, followed by 5 days of PPI + Clarithromycin + Tinidazole. * **Diagnosis:** The non-invasive "Gold Standard" for confirming eradication is the **Urea Breath Test (UBT)**.

Q: Which of the following drugs does NOT cause constipation?

Quinidine. The correct answer is **Quinidine**. **1. Why Quinidine is the correct answer:** Quinidine is a Class IA antiarrhythmic agent. Unlike many drugs that slow down gut motility, Quinidine is notorious for causing **diarrhea** (occurring in about 30-50% of patients) rather than constipation. This is often referred to as "Quinidine-induced syncope" if the resulting electrolyte imbalance leads to Torsades de Pointes. It does not possess significant anticholinergic or calcium-channel blocking effects on the GI smooth muscle that would lead to constipation. **2. Why the other options are incorrect:** * **Verapamil (Option A):** This is a non-dihydropyridine Calcium Channel Blocker (CCB). It is the CCB most strongly associated with **constipation** because it blocks L-type calcium channels in the colonic smooth muscle, significantly reducing peristalsis [1]. * **MAO Inhibitors (Option C):** Monoamine Oxidase Inhibitors (e.g., Phenelzine) frequently cause constipation as a common side effect due to their complex effects on the autonomic nervous system and peripheral neurotransmitter levels. * **Tricyclic Antidepressants (Option D):** TCAs (e.g., Amitriptyline, Imipramine) have potent **antimuscarinic (anticholinergic) properties**. By blocking M3 receptors on the intestinal smooth muscle, they decrease GI motility, leading to prominent constipation [2]. **3. High-Yield NEET-PG Pearls:** * **Verapamil** is the "classic" drug-induced constipation example in exams [1]. * **Anticholinergic Toxidrome:** Remember the mnemonic "Dry as a bone, Red as a beet, Mad as a hatter" – constipation is a key component due to decreased secretions and motility [2]. * **Other drugs causing constipation:** Opioids (via μ-receptors), Aluminum hydroxide antacids, and Iron supplements. * **Quinidine Side Effects:** Cinchonism (tinnitus, headache, dizziness), thrombocytopenia, and QT prolongation.

Q: Which of the following 5-HT3 blockers has the highest receptor affinity?

Palonosetron. ### Explanation **Correct Answer: D. Palonosetron** **1. Why Palonosetron is the Correct Answer:** Palonosetron is a **second-generation 5-HT3 receptor antagonist**. It is distinguished from first-generation agents (Ondansetron, Granisetron, Dolasetron) by its significantly **higher receptor affinity** (approximately 30 to 100 times higher) and a much longer elimination **half-life (~40 hours)**. Unlike other blockers, Palonosetron exhibits **allosteric binding** and triggers **receptor internalization**, leading to prolonged inhibition of the 5-HT3 receptor. Because of these properties, it is the only 5-HT3 antagonist FDA-approved for the prevention of **delayed chemotherapy-induced nausea and vomiting (CINV)**, whereas others are primarily effective for the acute phase. **2. Why Other Options are Incorrect:** * **A. Ondansetron:** The prototype first-generation 5-HT3 blocker. It has a short half-life (~3–4 hours) and lower binding affinity compared to Palonosetron. * **B. Granisetron:** A first-generation agent that is more potent than Ondansetron but still possesses significantly lower affinity and a shorter duration of action than Palonosetron. * **C. Dolasetron:** Another first-generation agent. Its active metabolite, hydrodolasetron, is responsible for its action. It is rarely used now due to the risk of **QTc interval prolongation**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Blocks 5-HT3 receptors on vagal afferents in the GI tract and the Chemoreceptor Trigger Zone (CTZ). * **Drug of Choice:** 5-HT3 blockers are the DOC for **CINV** and **Post-operative nausea and vomiting (PONV)**. * **Side Effects:** Headache (most common), constipation, and QTc prolongation (least risk with Palonosetron). * **Ineffectiveness:** These drugs are **not effective** in motion sickness (which is mediated by H1 and M1 receptors).

Q: Lubiprostone is a:

Chloride channel activator. **Explanation:** **Lubiprostone** is a bicyclic fatty acid derivative used primarily in the treatment of chronic idiopathic constipation and Irritable Bowel Syndrome with constipation (IBS-C). **1. Why Option A is Correct:** Lubiprostone acts as a selective **Chloride Channel Activator**. Specifically, it targets and activates the **type 2 chloride channels (ClC-2)** located on the apical (luminal) membrane of the intestinal epithelial cells. * **Mechanism:** Activation of these channels leads to an efflux of chloride ions into the intestinal lumen. * **Effect:** To maintain electroneutrality and osmotic balance, sodium ions and water follow the chloride into the lumen. This increased intestinal fluid secretion softens the stool and enhances intestinal motility, facilitating bowel movements. **2. Why Other Options are Incorrect:** * **Option B (Inhibitor):** Inhibiting chloride channels (e.g., using Crofelemer) would decrease fluid secretion, which is a strategy used for treating diarrhea, not constipation. * **Options C & D (Sodium Channels):** While sodium transport is vital for intestinal function, Lubiprostone does not directly bind to or modulate sodium channels. Its effect on sodium is secondary to the primary activation of chloride channels. **Clinical Pearls for NEET-PG:** * **Indications:** Chronic Idiopathic Constipation (CIC), IBS-C (in women), and Opioid-Induced Constipation (OIC). * **Pharmacokinetics:** It acts locally in the gut with minimal systemic absorption, reducing the risk of systemic side effects. * **Common Side Effect:** **Nausea** is the most frequently reported adverse effect (often dose-dependent). * **Comparison:** Unlike Linaclotide (which increases cGMP), Lubiprostone acts directly on the ClC-2 channel.

Q: Which agent is primarily used for the healing of stress ulcers?

H2 blockers. **Explanation:** **H2 Blockers (Option A)** are considered the drug of choice for the **prophylaxis and healing of stress-related mucosal damage (SRMD)** or stress ulcers. Stress ulcers typically occur in critically ill patients (e.g., those with severe burns, trauma, or sepsis) due to mucosal ischemia and back-diffusion of gastric acid. H2 blockers, such as Ranitidine or Famotidine, are preferred because they can be administered intravenously and have a proven track record in reducing the incidence of clinically significant gastrointestinal bleeding in ICU settings. **Why other options are incorrect:** * **Proton Pump Inhibitors (Option B):** While PPIs are more potent acid suppressors and are the gold standard for Peptic Ulcer Disease (PUD) and GERD, clinical trials have traditionally established H2 blockers as the primary agent for stress ulcer prophylaxis. However, PPIs are increasingly used off-label for this purpose. * **Antacids (Option C):** These neutralize existing acid but require frequent dosing (every 1-2 hours) via a nasogastric tube to be effective for stress ulcers, making them impractical and increasing the risk of aspiration pneumonia. * **Bismuth (Option D):** This is a mucosal protective agent used primarily in *H. pylori* eradication regimens and has no significant role in the management of acute stress ulcers. **High-Yield Clinical Pearls for NEET-PG:** * **Curling’s Ulcer:** Stress ulcer associated with severe **burns**. * **Cushing’s Ulcer:** Stress ulcer associated with **increased intracranial pressure** (vagal stimulation leads to hypersecretion of acid). * **Risk Factors:** The two strongest indications for stress ulcer prophylaxis in the ICU are **mechanical ventilation (>48 hours)** and **coagulopathy**. * **Adverse Effect:** Prolonged use of H2 blockers or PPIs in the ICU may increase the risk of **Nosocomial Pneumonia** (due to bacterial overgrowth in a less acidic stomach).

Q: Diarrhea is a side effect of which of the following drugs?

Misoprostol. Misoprostol is a synthetic prostaglandin $E_1$ ($PGE_1$) analog [1]. It is primarily used for the prevention of NSAID-induced gastric ulcers [1]. The correct answer is Misoprostol because diarrhea is its most common dose-limiting side effect (occurring in up to 30% of patients). Mechanism of Diarrhea: Misoprostol stimulates $EP_3$ receptors on intestinal mucosal cells, leading to increased secretion of electrolytes and water into the intestinal lumen. It also enhances intestinal motility through smooth muscle contraction, resulting in a prokinetic effect that manifests as diarrhea and abdominal cramping [4]. Analysis of Incorrect Options: * Omeprazole: A Proton Pump Inhibitor (PPI) [3]. While it can rarely cause diarrhea (associated with *C. difficile* infection due to hypochlorhydria), its most common side effects are headache and nausea. * Sucralfate: An aluminum salt of sulfated sucrose that forms a protective barrier over ulcers. Its most common side effect is constipation (due to the aluminum content), not diarrhea [2]. * Metoclopramide: A $D_2$ receptor antagonist used as a prokinetic. While it increases gastric emptying, its primary side effects are extrapyramidal symptoms (dystonia, parkinsonism) and hyperprolactinemia. High-Yield NEET-PG Pearls: * Misoprostol Contraindication: It is strictly contraindicated in pregnancy (Category X) as it causes uterine contractions and can lead to abortion [4]. * Clinical Use: It is used off-label for medical abortion (in combination with Mifepristone) and for the induction of labor/postpartum hemorrhage [4]. * NSAID Ulcers: While PPIs are now the preferred treatment, Misoprostol is the specific "mechanistic" drug for preventing NSAID-induced mucosal injury [1].

Question 1

Which selective 5-HT4 agonist is useful in gastroesophageal reflux disease and lacks arrhythmogenic properties?

Accepted Answer

Tegaserod

Answer

Buspirone

Answer

Sumatriptan

Answer

Cisapride

Question 2

Stimulant purgatives are contraindicated in which of the following conditions?

Accepted Answer

Subacute intestinal obstruction

Answer

Bedridden patients

Answer

Before abdominal radiography

Answer

All of these

Question 3

Which drug is not effective against Helicobacter pylori?

Accepted Answer

Erythromycin

Answer

Colloidal bismuth

Answer

Metronidazole

Answer

Amoxicillin

Question 4

Which of the following drugs does NOT cause constipation?

Accepted Answer

Quinidine

Answer

Verapamil

Answer

MAO inhibitor

Answer

Tricyclic antidepressants

Question 5

Which of the following is a prokinetic drug with no dopamine antagonism?

Accepted Answer

Mosapride

Answer

Chlorpromazine

Answer

Metaclopramide

Answer

Domperidone

Question 6

Which of the following 5-HT3 blockers has the highest receptor affinity?

Accepted Answer

Palonosetron

Answer

Ondansetron

Answer

Granisetron

Answer

Dolasetron

Question 7

Lubiprostone is a:

Accepted Answer

Chloride channel activator

Answer

Chloride channel inhibitor

Answer

Sodium channel activator

Answer

Sodium channel inhibitor

Question 8

Which agent is primarily used for the healing of stress ulcers?

Accepted Answer

H2 blockers

Answer

Proton pump inhibitors

Answer

Antacids

Answer

Bismuth

Question 9

Diarrhea is a side effect of which of the following drugs?

Accepted Answer

Misoprostol

Answer

Omeprazole

Answer

Sucralfate

Answer

Metoclopramide

Question 10

Which of the following antiemetics has less sedation and is used in motion sickness and vertigo?

Accepted Answer

Meclizine

Answer

Cyproheptadine

Answer

Chlorpheniramine

Answer

Promethazine

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?